The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update
The DOI matches its Crossref record; 163 of the 169 references it cites were found in a registry or an index.
Abstract
2020 Focused Update Guideline Committee members (alpha order): Chinazo Cunningham, MD, MS, FASAM Mark J. Edlund, MD, PhD Marc Fishman, MD, DFASAM Adam J. Gordon, MD, MPH, FACP, DFASAM Hendrée E. Jones, PhD Kyle M. Kampman, MD, FASAM, Chair Daniel Langleben, MD Marjorie Meyer, MD Sandra Springer, MD, FASAM George Woody, MD Tricia E. Wright, MD, MS, FACOG, DFASAM Stephen Wyatt, DO, FAOAAM, FASAM, Co-Chair 2019 Focused Update ASAM Quality Improvement Council (alpha order): John Femino, MD, DFASAM Kenneth Freedman, MD, MS, MBA, DFASAM, FACP, AGAF Chair R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM Barbara Herbert, MD, DFASAM Margaret Jarvis, MD, DFASAM Margaret Kotz, DO, DFASAM P. Stephen Novack, DO, MHCDS David R. Pating, MD, FASAM Sandrine Pirard, MD, PhD, MPH, FAPA, FASAM Maureen Boyle, PhD, ASAM Staff Taleen Safarian, ASAM Staff Leah White, ASAM Staff 2019 Focused Update Research Triangle Institute International (RTI) Team Members (alpha order):Karen Crotty, PhD, MPH, Principal Investigator Mark Edlund, MD, PhD Janice Tzeng, MPH Meera Viswanathan, PhD Brittany Zulkiewicz, BS Disclosure information for the 2019 focused update Guideline Committee members and the ASAM Quality Improvement Council is available, respectively, in Appendices VII and VIII. 2015 Guideline Committee Members(alpha order): Sandra Comer, PhD Chinazo Cunningham, MD, MS Marc J. Fishman, MD, FASAM Adam Gordon, MD, MPH, FASAM Kyle Kampman, MD, Chair Daniel Langleben, MD Ben Nordstrom, MD, PhD David Oslin, MD George Woody, MD Tricia Wright, MD, MS Stephen Wyatt, DO 2015 ASAM Quality Improvement Council (alpha order): John Femino, MD, FASAM Margaret Jarvis, MD, FASAM, Chair Margaret Kotz, DO, FASAM Sandrine Pirard, MD, MPH, PhD Robert J. Roose, MD, MPH Alexis Geier-Horan, ASAM Staff Beth Haynes, ASAM Staff Penny S. Mills, MBA, ASAM, Executive Vice-President Special External Reviewer: Michael M. Miller, MD, FASAM, FAPA 2015 Treatment Research Institute Technical Team Members (alpha order): Amanda Abraham, PhD Karen Dugosh, PhD David Festinger, PhD Kyle Kampman, MD, Principal Investigator Keli McLoyd, JD Brittany Seymour, BA Abigail Woodworth, MS Disclosure information for the 2015 Guideline Committee members, the ASAM Quality Improvement Council, and external reviewers is available respectively in Appendices IV, V, and VI ASAM is honored that this clinical practice guideline has been endorsed by: American Academy of Physician Assistants American Association of Nurse Anesthetists American College of Nurse-Midwives American College of Preventive Medicine American Osteopathic Academy of Addiction Medicine Federation of State Physician Health Programs International Nurses Society on Addictions National Association of Addiction Treatment Providers Table of ContentsAbbreviations and AcronymsAA – Alcoholics Anonymous ACOG – American College of Obstetrics and Gynecology ACT – Assertive Community Treatment AIDS – Acquired Immunodeficiency Syndrome ASAM – American Society of Addiction Medicine CBT – Cognitive Behavioral Therapy CDC – Centers for Disease Control and Prevention CNS – Central Nervous System COWS – Clinical Opioid Withdrawal Scale DATA 2000 – Drug Addiction Treatment Act of 2000 DEA – Drug Enforcement Agency DSM-4 – Diagnostic and Statistical Manual of Mental Disorders, 4th Edition DSM-5 – Diagnostic and Statistical Manual of Mental Disorders, 5th Edition ECG – Electrocardiogram EMS – Emergency Medical Services FDA – U.S. Food and Drug Administration HBV – Hepatitis B Virus HCV – Hepatitis C Virus HIV – Human Immunodeficiency Virus IDU – Injection Drug Use IM – Intramuscular IV – Intravenous NA – Narcotics Anonymous NAS Neonatal Absence Syndrome NIH – National Institutes of Health NIDA – National Institute on Drug Abuse NIAAA – National Institute on Alcohol Abuse and Alcoholism NOWS – Neonatal Opioid Withdrawal Syndrome NSAIDs – Nonsteroidal Anti-inflammatory Drugs NSDUH – National Survey on Drug Use and Health OBOT – Office-Based Opioid Treatment OOWS – Objective Opioid Withdrawal Scale OTP – Opioid Treatment Program PMDP – Prescription Drug Monitoring Program RCT – Randomized Controlled Trial RAM – RAND/UCLA Appropriateness Method SAMHSA – Substance Abuse and Mental Health Services Administration SMART – Self-Management and Recovery Therapy SOWS – Subjective Opioid Withdrawal Scale TB – Tuberculosis UROD – Ultra-rapid Opioid Detoxification National Practice Guideline Glossary Abstinence: Intentional and consistent restraint from the pathological pursuit of reward and/or relief that involves the use of substances and other behaviors. These behaviors may involve, but are not necessarily limited to substance use, gambling, video gaming, or compulsive sexual behaviors.1 Use of FDA approved medications for the treatment of substance use disorder is consistent with abstinence. Abuse: This term is not recommended for use in clinical or research contexts. Harmful use of a specific psychoactive substance. When used to mean substance abuse, this term pre
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“use of BZDs is not a reason to withhold or suspend treatment with methadone or buprenorphine for the treatment of opioid use disorder (OUD; see “Patients with Benzodiazepine and Other Substance Use Disorders”).”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [145]
In the citing paper
“Patients with OUD should typically be initiated and stabilized on medications for OUD (MOUD) prior to initiating a BZD taper, and the MOUD dose should be kept stable throughout the BZD tapering process.145,146”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [145]
Citations
Cites
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1259 · Cited by 2,538
National Conference of State Legislatures
(2011) · Reference Reviews · doi:10.1108/09504121111114072 · Cited by 2,315
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,267
The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013
Florence, C. S., Zhou, C., Luo, F., & Xu, L. (2016) · Medical Care · doi:10.1097/mlr.0000000000000625 · Cited by 1,152
The Clinical Opiate Withdrawal Scale (COWS)
Wesson, D. R., & Ling, W. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400007 · Cited by 1,120
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3107 · Cited by 1,076
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005359 · Cited by 986
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements
Dixon, L. B., Dickerson, F., Bellack, A. S., Bennett, M., Dickinson, D., Goldberg, R. W., Lehman, A., Tenhula, W. N., Calmes, C., Pasillas, R. M., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp115 · Cited by 774
Research works printed but not linked: 1
- Brunette, 2006, Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder, J Clin Psychiatry, 67, 10
Cited by
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
Dowell, D., Brown, S., Gyawali, S., Hoenig, J., Ko, J., Mikosz, C., Ussery, E., Baldwin, G., Jones, C. M., Olsen, Y., et al. (2024) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7325a1 · Cited by 261
Dufort, A., & Samaan, Z. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00893-z · Cited by 140
Clinical management of the alcohol withdrawal syndrome
Day, E., & Daly, C. (2021) · Addiction · doi:10.1111/add.15647 · Cited by 104
Weimer, M. B., Herring, A. A., Kawasaki, S. S., Meyer, M. C., Kleykamp, B. A., & Ramsey, K. S. (2023) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001202 · Cited by 94
Metadata
- Venue
- Journal of Addiction Medicine
- Published
- 2020-03
- Volume
- 14
- Issue
- 2S
- Pages
- 1-91
- ISSN
- 1932-0620 (ISSN-L)
- 1935-3227
- OpenAlex
- W3205115907
- Cited by
- 412
- References
- 169
- Citations by year
- 2026: 61 · 2025: 82 · 2024: 92 · 2023: 76 · 2022: 49 · 2021: 47 · 2020: 5
- FWCI
- 33.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Addiction Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- opioid use disorder, addiction treatment, medication-assisted treatment, buprenorphine, naltrexone, methadone, harm reduction, opioid substitution therapy, quality improvement, patient-centered care
- MeSH terms
- Analgesics, Opioid, Female, Humans, Male, Opioid-Related Disorders, Pregnancy, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. https://app.cochat.ai/papers/10.1097/adm.0000000000000633
- The paper
- The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. (2020). Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000000633
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.